Literature DB >> 29263720

The changing profile of hypercalcemia in a tertiary care setting in North India: an 18-month retrospective study.

Mohammad Shafi Kuchay1, Parjeet Kaur1, Sunil Kumar Mishra1, Ambrish Mithal1.   

Abstract

This retrospective study was undertaken to determine the profile of hypercalcemia in all patients who presented to Medanta-The Medicity, a tertiary care hospital in North India. A total of 255,830 patients presented to the hospital during 1st January 2014 till 30th June 2015 (18 months). Among them calcium measurement was done in 26,297 (10.2%) patients. A total of 552 patients was found to have hypercalcemia. Among them, 15 (2.7%) patients had transient hypercalcemia and 537 (97.3%) had sustained hypercalcemia. The incidence of hypercalcemia was 2.09%, being transient in 0.05% and sustained in 2.04%. The most common causes in the sustained group were malignancy (23.1%) followed by primary hyperparathyroidism (PHPT, 21.9%). Most cases of PHPT were asymptomatic. Interestingly, we found emergence of two unusual groups of hypercalcemia, namely hypercalcemia of advanced chronic liver disease (n = 34) and vitamin D toxicosis (n = 21) in the non-parathyroid group of hypercalcemia. This changing pattern of hypercalcemia should be kept in mind while evaluating a patient of hypercalcemia in a hospital setting.

Entities:  

Keywords:  chronic liver disease; granulomatous disease; hypercalcemia; hypervitaminosis D; malignancy; thyrotoxicosis; vitamin D toxicosis

Year:  2017        PMID: 29263720      PMCID: PMC5726196          DOI: 10.11138/ccmbm/2017.14.1.131

Source DB:  PubMed          Journal:  Clin Cases Miner Bone Metab        ISSN: 1724-8914


  28 in total

Review 1.  Hypercalcemia of malignancy.

Authors:  V Grill; T J Martin
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Leprosy, hypercalcemia, and elevated serum calcitriol levels.

Authors:  V N Hoffman; O M Korzeniowski
Journal:  Ann Intern Med       Date:  1986-12       Impact factor: 25.391

3.  Hypercalcemia in disseminated candidiasis.

Authors:  H M Kantarjian; M F Saad; E H Estey; R V Sellin; N A Samaan
Journal:  Am J Med       Date:  1983-04       Impact factor: 4.965

4.  Vitamin d toxicity in adults: a case series from an area with endemic hypovitaminosis d.

Authors:  Parvaiz A Koul; Sheikh Hilal Ahmad; Feroze Ahmad; Rafi A Jan; S U Shah; Umar H Khan
Journal:  Oman Med J       Date:  2011-05

5.  Hyperthyroidism manifested as hypercalcemia.

Authors:  Z Alikhan; A Singh
Journal:  South Med J       Date:  1996-10       Impact factor: 0.954

6.  Hypercalcemia due to subacute thyroiditis.

Authors:  T B Kaye
Journal:  Endocr Pract       Date:  1997 Nov-Dec       Impact factor: 3.443

7.  Clinical and laboratory profile of primary hyperparathyroidism in India.

Authors:  G Priya; V P Jyotsna; N Gupta; S Chumber; C S Bal; A K Karak; A Seth; A C Ammini
Journal:  Postgrad Med J       Date:  2008-01       Impact factor: 2.401

8.  Vitamin D toxicity resulting from overzealous correction of vitamin D deficiency.

Authors:  Parjeet Kaur; Sunil Kumar Mishra; Ambrish Mithal
Journal:  Clin Endocrinol (Oxf)       Date:  2015-07-14       Impact factor: 3.478

9.  "Excess gooD can be Dangerous". A case series of iatrogenic symptomatic hypercalcemia due to hypervitaminosis D.

Authors:  Kamal Kishore Pandita; Sushil Razdan; Rattan Parkash Kudyar; Aadil Beigh; Shafi Kuchay; Tanveer Banday
Journal:  Clin Cases Miner Bone Metab       Date:  2012-09-30

10.  Hypercalcemia due to hypervitaminosis D: report of seven patients.

Authors:  Rajesh Joshi
Journal:  J Trop Pediatr       Date:  2009-04-01       Impact factor: 1.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.